6 June 2022
Sofia, Bulgaria, June 6, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for May 2022 the Company recorded an increase in sales of 16% compared to the same month of the previous year, incl. 24% decrease in domestic sales and 77% increase in export sales.
For the five months since the beginning of the year the revenues from sales of products increase by 28%, incl. 35% increase of sales for the domestic market and 24% increase in export sales.